The Current Ratio as of September 2024 (TTM) for AgeX Therapeutics, Inc. (AGE) is 0.64

According to AgeX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.64. This represents a change of 116.52% compared to the average of 0.29 of the last 4 quarters.

AgeX Therapeutics, Inc. (AGE) Historical Current Ratio (quarterly & annually)

How has AGE Current Ratio performed in the past?

The mean historical Current Ratio of AgeX Therapeutics, Inc. over the last ten years is 1.61. The current 0.64 Current Ratio has changed 3.84% with respect to the historical average. Over the past ten years (40 quarters), AGE's Current Ratio was at its highest in in the June 2018 quarter at 9.06. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

AgeX Therapeutics, Inc. (AGE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AgeX Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AgeX Therapeutics, Inc. (AGE) Average Current Ratio

How has AGE Current Ratio performed in the past?

The current Current Ratio of AgeX Therapeutics, Inc. (AGE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

AgeX Therapeutics, Inc. (AGE) Current Ratio vs. Peers

How is AGE’s Current Ratio compared to its peers?

AgeX Therapeutics, Inc.’s Current Ratio is less than MAIA Biotechnology, Inc. (3.42), less than Larimar Therapeutics, Inc. (10.93), less than Graphite Bio, Inc. (11.47), less than Lyra Therapeutics, Inc. (3.60), less than Lineage Cell Therapeutics, Inc. (2.64), less than Cadrenal Therapeutics, Inc. Common Stock (3.60), less than ImmuCell Corporation (2.37), less than Oxford Nanopore Technologies plc (4.45), less than Praxis Precision Medicines, Inc. (0), less than Foghorn Therapeutics Inc. (17.30), less than Synaptogenix, Inc. (5.69), less than Invivyd, Inc. (2.98), less than Biohaven Pharmaceutical Holding Company Ltd. (4.71), less than Immunome, Inc. (3.27), less than Inhibrx, Inc. (7.12), less than Icosavax, Inc. (6.20), less than null (18.06),

Build a custom stock screener for AgeX Therapeutics, Inc. (AGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgeX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AgeX Therapeutics, Inc. (AGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AgeX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.